glp-1 receptor agonist function actions and target organs. GLP-1, through its GLP-1R, Trends in the Development of
Description
Chem Rev
Cardiology and Therapy
What happens when you stop treatment
Additional observations from Phase 2 data include: Mild increases in heart rate, attributed to the glucagon receptor component
Curr Diabetes Rev 14(3):273279 Mousavi A et al (2025) Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
